Novel Therapeutic Approaches to Multiple Sclerosis: BTK and Second-Generation Anti-CD40 Therapeutics

Dec 12, 2025

- Dec 11, 2026

1.0

Claim your AMA PRA Category 1 Credit

This course is available for logged in users only. Please login or register to take the course.

Management of Patients with Non-Cystic Fibrosis Bronchiectasis: Reducing Burden of Disease...

Clinical Update on the Evolving Role of B-Cell Targeting Therapies to Improve Outcomes in ...

Beyond Symptom Control: Targeting BAFF/APRIL Pathways in Generalized Myasthenia Gravis